ACT MALI: Treatment of Malaria Based on Combination Therapies

PHASE4CompletedINTERVENTIONAL

Enrollment

780

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Malaria

Interventions

DRUG

Artesunate

oad, per os, 3 days of treatment

DRUG

Artesunate + Sulfadoxine-Pyrimethamine

oad, per os

DRUG

arthemether + lumefantrine

bid, per os. Duration of treatment: 3 days

Trial Locations (1)

Sanofi-Aventis Administrative Office, Bougoula